D-0441-2024 Class III
Recall Details
- Product Type
- Drugs
- Report Date
- April 24, 2024
- Initiation Date
- March 27, 2024
- Termination Date
- N/A
- Voluntary/Mandated
- Voluntary: Firm initiated
- Product Quantity
- 3,480 30-count bottles
Product Description
NEXLIZET (bempedoic acid and ezetimibe) tablets, 180 mg/10 mg, 30-count bottle, Rx only, Manufactured for: Esperion Therapeutics, Ann Arbor, MI 48108, NDC 72426-818-03
Reason for Recall
Failed dissolution specifications: out-of-specification bempedoic acid dissolution at the 0-month timepoint.
Distribution Pattern
Nationwide in the USA
Code Information
Lot #, 1990305, Exp 08-31-2025